Atlas Trials

Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet

Clinical trial NCT01004614 · COMPLETED

Trial details

NCT number
NCT01004614
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2009-11-01
Primary completion
2009-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.